Global Newborn Screening for SMA and SCID Competitive Landscape Professional Research Report 2025
Research Summary
Newborn screening for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID) involves testing newborn infants shortly after birth to detect these genetic disorders early on, even before symptoms appear. SMA is a genetic condition that affects the motor neurons, leading to muscle weakness and loss of movement. SCID is a rare, life-threatening condition that affects the immune system, leaving infants susceptible to severe infections. Screening for SMA involves identifying specific genetic markers or mutations associated with the condition. Similarly, SCID screening detects the absence or dysfunction of immune cells. Early detection of SMA and SCID allows for timely medical interventions, such as gene therapy, enzyme replacement therapy, or bone marrow transplantation, which can significantly improve outcomes and increase the chances of effective treatment. Newborn screening for SMA and SCID aims to ensure that affected infants receive appropriate medical care and support as early as possible, preventing complications and improving their quality of life.
According to DIResearch's in-depth investigation and research, the global Newborn Screening for SMA and SCID market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Newborn Screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Newborn Screening for SMA and SCID. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Newborn Screening for SMA and SCID market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Newborn Screening for SMA and SCID market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Newborn Screening for SMA and SCID industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Newborn Screening for SMA and SCID Include:
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Newborn Screening for SMA and SCID Product Segment Include:
Instruments
Kits
Software
Newborn Screening for SMA and SCID Product Application Include:
SCID Screening
SMA Screening
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Newborn Screening for SMA and SCID Industry PESTEL Analysis
Chapter 3: Global Newborn Screening for SMA and SCID Industry Porter’s Five Forces Analysis
Chapter 4: Global Newborn Screening for SMA and SCID Major Regional Market Size and Forecast Analysis
Chapter 5: Global Newborn Screening for SMA and SCID Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Newborn Screening for SMA and SCID Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Newborn Screening for SMA and SCID Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Newborn Screening for SMA and SCID Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Newborn Screening for SMA and SCID Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Newborn Screening for SMA and SCID Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Newborn Screening for SMA and SCID Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Newborn Screening for SMA and SCID Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Newborn Screening for SMA and SCID Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Newborn Screening for SMA and SCID Product by Type
- 1.2.1 Instruments
- 1.2.2 Kits
- 1.2.3 Software
- 1.3 Newborn Screening for SMA and SCID Product by Application
- 1.3.1 SCID Screening
- 1.3.2 SMA Screening
- 1.4 Global Newborn Screening for SMA and SCID Market Size Analysis (2020-2032)
- 1.5 Newborn Screening for SMA and SCID Market Development Status and Trends
- 1.5.1 Newborn Screening for SMA and SCID Industry Development Status Analysis
- 1.5.2 Newborn Screening for SMA and SCID Industry Development Trends Analysis
- 2 Newborn Screening for SMA and SCID Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Newborn Screening for SMA and SCID Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Newborn Screening for SMA and SCID Market Analysis by Regions
- 4.1 Newborn Screening for SMA and SCID Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Newborn Screening for SMA and SCID Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Newborn Screening for SMA and SCID Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Newborn Screening for SMA and SCID Revenue Forecast by Region (2026-2032)
- 5 Global Newborn Screening for SMA and SCID Market Size by Type and Application
- 5.1 Global Newborn Screening for SMA and SCID Market Size by Type (2020-2032)
- 5.2 Global Newborn Screening for SMA and SCID Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Newborn Screening for SMA and SCID Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Newborn Screening for SMA and SCID Market Size by Type
- 6.4 North America Newborn Screening for SMA and SCID Market Size by Application
- 6.5 North America Newborn Screening for SMA and SCID Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Newborn Screening for SMA and SCID Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Newborn Screening for SMA and SCID Market Size by Type
- 7.4 Europe Newborn Screening for SMA and SCID Market Size by Application
- 7.5 Europe Newborn Screening for SMA and SCID Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Newborn Screening for SMA and SCID Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Newborn Screening for SMA and SCID Market Size by Type
- 8.4 China Newborn Screening for SMA and SCID Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Newborn Screening for SMA and SCID Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Newborn Screening for SMA and SCID Market Size by Type
- 9.4 APAC (excl. China) Newborn Screening for SMA and SCID Market Size by Application
- 9.5 APAC (excl. China) Newborn Screening for SMA and SCID Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Newborn Screening for SMA and SCID Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Newborn Screening for SMA and SCID Market Size by Type
- 10.4 Latin America Newborn Screening for SMA and SCID Market Size by Application
- 10.5 Latin America Newborn Screening for SMA and SCID Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Type
- 11.4 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Application
- 11.5 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Newborn Screening for SMA and SCID Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Newborn Screening for SMA and SCID Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Newborn Screening for SMA and SCID Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Perkinelmer
- 13.1.1 Perkinelmer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Portfolio
- 13.1.3 Perkinelmer Newborn Screening for SMA and SCID Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Thermo Fisher
- 13.2.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Portfolio
- 13.2.3 Thermo Fisher Newborn Screening for SMA and SCID Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 ImmunoIVD
- 13.3.1 ImmunoIVD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Portfolio
- 13.3.3 ImmunoIVD Newborn Screening for SMA and SCID Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Labsystems Diagnostics
- 13.4.1 Labsystems Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Portfolio
- 13.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Newborn Screening for SMA and SCID Industry Chain Analysis
- 14.2 Newborn Screening for SMA and SCID Industry Raw Material and Suppliers Analysis
- 14.2.1 Newborn Screening for SMA and SCID Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Newborn Screening for SMA and SCID Typical Downstream Customers
- 14.4 Newborn Screening for SMA and SCID Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook